Warfarin is associated with higher rates of upper gastrointestinal (GI) bleeding but not overall or lower gastrointestinal bleeding rates compared with direct oral anticoagulants (DOACs), according to ...
Nearly 70% of patients with acute upper gastrointestinal (GI) bleeding and low-risk or no peptic ulcer disease received intravenous (IV) proton pump inhibitors (PPIs) inappropriately, leading to ...
A study published in The Lancet examined celecoxib use versus naproxen in patients with cardiothrombotic diseases and arthritis. Francis K. L. Chan, MD, of the Chinese University of Hong Kong, and ...
Pantoprazole yields lower clinically important upper GI bleeding, with no significant change in mortality vs placebo. HealthDay News — Pantoprazole results in a significantly lower risk for clinically ...
Patients who developed upper gastrointestinal (GI) bleeding during a hospital stay experienced worse adverse outcomes than those admitted for upper GI bleeding alone, French researchers found in a ...
Please provide your email address to receive an email when new articles are posted on . In patients with acute MI, upper gastrointestinal bleeding occurred in 1.5% within 1 year and was associated ...
Please provide your email address to receive an email when new articles are posted on . “GI bleeding is the most common GI reason for hospitalization in the U.S. and thus the most common emergency ...
LONG BEACH, Calif. -- People with advanced chronic kidney disease (CKD) faced higher rates of potentially fatal gastrointestinal bleeding, a retrospective study found. Those with stage 5 CKD had a 40% ...
The American College of Gastroenterology published updated guidelines on managing upper gastrointestinal and ulcer bleeding in the May 2021 issue of The American Journal of Gastroenterology. The ...
MADRID, Spain—Routine screening for Helicobacter pylori infection across a broad range of patients hospitalized with acute MI does not significantly reduce rates of upper GI bleeding, the HELP-MI ...
Konvomep contains 2mg of omeprazole, a proton pump inhibitor, and 84mg of sodium bicarbonate per mL after reconstitution. The Food and Drug Administration (FDA) has approved Konvomep ™ (omeprazole and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results